1. Home
  2. Our Firm
  3. News
  4. Guggenheim Securities Expands Equity Capital Markets Practice

Our Firm

October 09, 2014

Guggenheim Securities Expands Equity Capital Markets Practice

Appointments Advance Guggenheim’s Traditional and Alternative Capital Markets Capabilities

NEW YORK – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners (“Guggenheim”), today announced the appointment of Richard E. Gormley as Senior Managing Director, Head of Equity and Equity-linked Finance, with responsibility for leading the traditional and alternative capital markets businesses. Mr. Gormley is joined by James Lee, Managing Director, and Michael Jiang, Associate, as part of the expansion of Guggenheim’s corporate finance practice.

“We are pleased to welcome Richard and his team,” said Alan Schwartz, Executive Chairman of Guggenheim Partners and CEO of Guggenheim Securities. “Richard’s longstanding track record and stellar reputation in the growth financing markets underscores our commitment to hiring senior talent with deep experience as we continue to invest in our investment banking and capital markets capabilities.”

Mark Van Lith, Head of Investment Banking at Guggenheim, added: “Richard and his team will complement and enhance the Firm’s existing focus on providing innovative financing solutions to our clients.”

“James, Michael and I are excited to join the Guggenheim team,” Mr. Gormley said. “The Firm has great momentum. Clients crave thoughtful, objective strategic and financial advice from their bankers. Guggenheim’s approach of providing rigorous intellectual capital through a partnership culture in the service of clients is powerful. We look forward to working with our new partners in offering clients valuable ideas and best-in-class execution.”

Mr. Gormley has nearly 30 years of experience in the investment banking and capital markets industry, having completed $20 billion of public and private financing transactions across a variety of industries and securities structures. Most recently, he was a Vice Chairman of Lazard Frères, where he led the firm’s prolific Alternative Capital Finance business. Prior to Lazard, he was a Managing Director and held senior leadership positions in the capital markets businesses of Cowen and Company and Rabobank International. Mr. Gormley began his career in the corporate finance groups at Citibank and Nesbitt Burns Securities (and its predecessor companies, including Security Pacific/Burns Frey).


About Guggenheim Partners

Guggenheim Partners is a global investment and advisory firm with more than $210 billion in assets under management. Across our three primary businesses of investment management, investment banking, and insurance services, we have a track record of delivering results through innovative solutions. With more than 2,500 professionals based in more than 25 offices around the world, our commitment is to advance the strategic interests of our clients and to deliver long-term results with excellence and integrity.



November 09, 2020

Guggenheim Securities Hires David Levin to Expand Equity Capital Markets

NEW YORK, NY –  Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that David Levin will join the firm as a Senior Managing Director in Equity Capital Markets, focusing on providing clients with equity and equity-linked financing solutions through the public and alternative equity capital markets.

Read More

October 22, 2020

Guggenheim Securities Hires Joe Niemiec to Expand Middle Market Investment Banking Practice

NEW YORK, NY – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Joe Niemiec has joined the firm as a Senior Managing Director to expand its middle market investment banking coverage and to focus on advising companies in the services and industrials sectors.

Read More

October 05, 2020

Debjit Chattopadhyay Joins Guggenheim Securities as Senior Biotech Analyst

NEW YORK, NY – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Debjit Chattopadhyay will join the firm in December as a Managing Director and Senior Biotech Analyst as part of the Healthcare Equity Research team. Dr. Chattopadhyay’s research focus will be gene therapy and rare diseases.

Read More



© 2020 Guggenheim Partners, LLC. All rights reserved. Guggenheim, Guggenheim Partners and Innovative Solutions. Enduring Values. are registered trademarks of Guggenheim Capital, LLC.